These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25953283)

  • 21. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla.
    Klumpp B; Fenchel M; Hoevelborn T; Helber U; Scheule A; Claussen C; Miller S
    Invest Radiol; 2006 Sep; 41(9):661-7. PubMed ID: 16896300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of 3-T magnetic resonance imaging in local staging of prostate cancer.
    Fütterer JJ; Barentsz JO; Heijmink SW
    Top Magn Reson Imaging; 2008 Dec; 19(6):285-9. PubMed ID: 19512850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR imaging of the pancreas: 1.5T versus 3T.
    Edelman RR
    Magn Reson Imaging Clin N Am; 2007 Aug; 15(3):349-53, vi. PubMed ID: 17893054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR imaging of benign focal liver lesions.
    Ba-Ssalamah A; Baroud S; Bastati N; Qayyum A
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):403-19, ix. PubMed ID: 21094447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3-Tesla high-resolution MR imaging of the wrist.
    Saupe N
    Semin Musculoskelet Radiol; 2009 Mar; 13(1):29-38. PubMed ID: 19235670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of 3.0-T MR imaging for evaluation of the abdomen.
    Erturk SM; Alberich-Bayarri A; Herrmann KA; Marti-Bonmati L; Ros PR
    Radiographics; 2009 Oct; 29(6):1547-63. PubMed ID: 19959507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of 3-T cardiovascular magnetic resonance imaging.
    Lohan DG; Saleh R; Tomasian A; Krishnam M; Finn JP
    Top Magn Reson Imaging; 2008 Feb; 19(1):3-13. PubMed ID: 18690156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrahigh-field 7-T magnetic resonance carotid vessel wall imaging: initial experience in comparison with 3-T field strength.
    Kröner ES; van Schinkel LD; Versluis MJ; Brouwer NJ; van den Boogaard PJ; van der Wall EE; de Roos A; Webb AG; Siebelink HM; Lamb HJ
    Invest Radiol; 2012 Dec; 47(12):697-704. PubMed ID: 22996317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ophthalmic magnetic resonance imaging at 7 T using a 6-channel transceiver radiofrequency coil array in healthy subjects and patients with intraocular masses.
    Graessl A; Muhle M; Schwerter M; Rieger J; Oezerdem C; Santoro D; Lysiak D; Winter L; Hezel F; Waiczies S; Guthoff RF; Falke K; Hosten N; Hadlich S; Krueger PC; Langner S; Stachs O; Niendorf T
    Invest Radiol; 2014 May; 49(5):260-70. PubMed ID: 24651662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of the spine at 3 tesla.
    Shapiro M
    Neuroimaging Clin N Am; 2012 May; 22(2):315-41, xi-xii. PubMed ID: 22548935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke imaging at 3.0 T.
    Lauzon ML; Sevick RJ; Demchuk AM; Frayne R
    Neuroimaging Clin N Am; 2006 May; 16(2):343-66, xii. PubMed ID: 16731371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.
    Wintersperger BJ; Runge VM; Biswas J; Reiser MF; Schoenberg SO
    Invest Radiol; 2007 Aug; 42(8):558-63. PubMed ID: 17620938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High accuracy and contrast resolution in ultra-low field magnetic resonance imaging.
    Agartz I; Sääf J; Wahlund B; Wahlund LO; Wetterberg L
    Acta Radiol Suppl; 1986; 369():472-4. PubMed ID: 2980531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo 35Cl MR imaging in humans: a feasibility study.
    Nagel AM; Lehmann-Horn F; Weber MA; Jurkat-Rott K; Wolf MB; Radbruch A; Umathum R; Semmler W
    Radiology; 2014 May; 271(2):585-95. PubMed ID: 24495267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases.
    Ba-Ssalamah A; Nöbauer-Huhmann IM; Pinker K; Schibany N; Prokesch R; Mehrain S; Mlynárik V; Fog A; Heimberger K; Trattnig S
    Invest Radiol; 2003 Jul; 38(7):415-22. PubMed ID: 12821855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.
    Spuentrup E; Ruhl KM; Botnar RM; Wiethoff AJ; Buhl A; Jacques V; Greenfield MT; Krombach GA; Günther RW; Vangel MG; Caravan P
    Circulation; 2009 Apr; 119(13):1768-75. PubMed ID: 19307474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing 1.5-Tesla and 3-Tesla dynamic contrast-enhanced magnetic resonance imaging of the breasts.
    Chatterji M; Mercado CL; Moy L
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):207-24, viii. PubMed ID: 20494307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic field strength increase yields significantly greater contrast-to-noise ratio increase: Measured using BOLD contrast in the primary visual area.
    Okada T; Yamada H; Ito H; Yonekura Y; Sadato N
    Acad Radiol; 2005 Feb; 12(2):142-7. PubMed ID: 15721590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic contrast-enhanced breast MR imaging.
    Moon M; Cornfeld D; Weinreb J
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.